MedTrace Logo

Supermicrosurgical Lymphvenous Bypass Intervention for Treatment

NCT05270629 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2022-03-08

No results posted yet for this study

Summary

Background: In addition to antegrade anastomosis, retrograde anastomosis has been thought to offer further improvements after lymphaticovenous anastomosis (LVA) by bypassing the retrograde lymphatic flow. However, this concept has yet to be validated. The aim of this study was to determine the impacts on outcomes of performing both retrograde and antegrade anastomosis, as compared to antegrade-only anastomosis for treating lower limb lymphedema.

Conditions

  • Lymphedema of Leg

Interventions

OTHER

Antegrade and retrograde anastomoses

Patients who had received both antegrade and retrograde anastomoses.

OTHER

Antegrade-only anastomoses

Patients who had received antegrade-only anastomoses.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-06
Primary Completion
2022-08-31
Completion
2022-09-05

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05270629 on ClinicalTrials.gov